Insiders who reported open-market trades in the last 12 months at the companies George M. Jenkins files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Kathleen Goin - $5.09M in PVLA purchases and sales in the last 12 months
Elaine J. Heron - $300K in PVLA purchases and sales in the last 12 months
George M. Jenkins is a corporate insider, tracked as Director of PALVELLA THERAPEUTICS, INC. (PVLA). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has George M. Jenkins submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has George M. Jenkins been buying or selling stock?
Recorded transactions: 5 open-market purchases ($702K) and 9 open-market sales ($4.17M) across all tracked filings.
George M. Jenkins is Director of PALVELLA THERAPEUTICS, INC. (PVLA). 8 SEC Form 4 filings on record going back to 2024, most recently on 16 September 2026. Most recent open-market trade: sold $85K of PVLA on 16 September 2026. Lifetime open-market purchases: $702K. Lifetime open-market sales: $4.17M.
Recent transactions
14
The latest 14 SEC Form 4 transactions reported by George M. Jenkins.
InsiderAlpha's records for George M. Jenkins go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. The typical open-market purchase is $140K (5 buys totaling $702K). The largest single buy on record is $500K of PVLA in 2026. Sales side: 9 recorded sales totaling $4.17M, so the filing history runs sell-heavy by dollar value. 9 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
